MANIPALHOS · Manipal Health Enterprises Ltd · Healthcare Facilities
MANIPALHOS · Manipal Health Enterprises Ltd · Healthcare Facilities
As of 05 Nov close
Price chartDaily closes on the stock page.
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Full signal detail →Fundamentals as of 16 Oct 2026
Revenue (latest Q)
₹3,091 Cr
Revenue YoY
PAT YoY
-7.5%
Operating margin
Revenue, last 4 quarters
Source: Yahoo Finance, as of 30 Jun 2026
P/E (TTM)
P/B
8.9
P/S (TTM)
7.6
Sector P/E
29
Dividend yield
0.0%
Source: Yahoo Finance, as of 29 Oct 2026
| Company | P/E | P/B | Net margin | ROE | D/E | Div. yield |
|---|---|---|---|---|---|---|
| MANIPALHOS (this stock) | 132 | 8.9 | +7.8% | Not available from data source | 1.53 | 0.0% |
| Apollo Hospitals Enterprise | 65.3 | 13.5 | Not available from data source | Not available from data source | Not available from data source | Not available from data source |
| Max Healthcare Institute | 67.6 | 9.3 | Not available from data source | Not available from data source | Not available from data source | Not available from data source |
| Aster DM Healthcare * | 126.9 | 15.5 | +6.5% | +7.0% | 0.49 | +0.4% |
* Net margin, ROE, D/E and dividend yield for these companies come from RedixFi fundamentals; the data vendor had no values for them.
Promoter
stable
FII
stable
MF
3.53%
stable
Insider trades
No insider trades in the last 12 months.
Bulk/block deals
No bulk/block deals in the last 12 months.
News timeline
No related news.
Concalls & investor presentations
AI-generatedKey takeaway: Manipal Health Enterprises Limited reported Q1 FY27 revenue of INR3,091 crores, a 38% year-on-year growth, with network EBITDA of INR749 crores, up 26% YoY. Excluding a one-off gain, EBITDA growth was over 30%. Operating margins stood at 25% (excluding Sahyadri) and 24.2% including Sahyadri. Inpatient volumes rose 39%, OP volumes 26%, and average occupancy increased 290 bps to 65%. Digital revenue contributed INR710 crores (23% of total revenue). Sahyadri Hospitals reported revenue growth of 13% and EBITDA growth of 19%, with ARPOB at INR45,000/day and occupancy at 63%. The company added 103 beds in Nashik and launched its 50th hospital in Bangalore, adding 300 beds. A Kinder Hospital acquisition in Whitefield added 100 beds. Management emphasized volume-led growth, operational efficiency, and integration of Sahyadri into the Manipal network over 18 months. Greenfield hospitals in Bengaluru, Raipur, and Mumbai are expected to drive future growth, with capex of INR4,000 crores planned over 3-4 years. Net debt-to-EBITDA is projected to reduce to 0.9x post-IPO. The company aims to expand into Kerala, NCR, and Hyderabad through inorganic opportunities.
The document highlights strong revenue and EBITDA growth, operational improvements, and strategic expansions, with management expressing confidence in future growth drivers.
Sourced from an exchange-filed transcript, dated 27 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.
Governance disclosures
AI-generatedNo governance disclosures identified in MANIPALHOS's filed documents yet.